December 18, 2014 Approval Letter - INTERCEPT Blood System for Platelets

Intended to be used for ex vivo preparation of apheresis platelet components in order to reduce the risk of transfusion-transmitted infection (TTI) including sepsis, and to potentially reduce the risk of transfusion-associated graft versus host disease (TA-GVHD).

via Whats New Vaccines Blood Biologics RSS Feed http://bit.ly/2Q4Gq5m